Locations:

Research

March 18, 2020/Cancer/Research

Chemo Plus Immunotherapy Shows Promise for Advanced Bladder Cancer

New neoadjuvant treatment regimen offers hope to patients facing a poor prognosis

March 17, 2020/Cancer/Research

Study Reinforces Concerns about Dietary Supplement Use and Breast Cancer Treatment

Some supplements associated with negative patient outcomes

March 5, 2020/Cancer/Research

Assessing Outcomes for Patients with Uveal Melanoma Metastatic to the Liver

Early screening, first-line therapy choice critical

February 24, 2020/Cancer/Research

Researchers Validate Link Between Genetic Variant and Poor Outcomes in Advanced Prostate Cancer

Cleveland Clinic-led study lays groundwork for more personalized treatments

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

February 3, 2020/Cancer/Research

New Approach Leads to Transfusion Independence in Low-risk MDS

Luspatercept shows promise for patients with few options

January 29, 2020/Cancer/Research

NCI Grant to Cleveland Clinic Scientist Will Support Evolution-Based Cancer Research

Searching for new insights into drug resistance, collateral sensitivity

January 23, 2020/Cancer/Research

Top 10 Takeaways from ASH 2019

These research results will have impact in 2020

January 15, 2020/Cancer/Research

New Clinic Tackles Mutations That Increase Risk of Blood Cancers and Heart Disease

CHIP Clinic's goals: Research, preventive care

December 12, 2019/Cancer/Research

No Survival Advantage from Chemo-endocrine Therapy over Endocrine Therapy in Invasive Lobular Carcinoma

Study suggests limited role for CET in this cancer type

December 9, 2019/Cancer/Research

Lenalidomide/Monoclonal Antibody Combination Superior to PI3K Inhibitor Monotherapy as First Novel Agent in Relapsed Follicular Lymphoma

Study assesses outcomes of therapies with novel agents

BackPage 14 of 42Next